On CBSNews.com: Aniston: What Jolie Did Was "Uncool"
Find Articles in:
all
Business
Reference
Technology
News
Sports
Health
Autos
Arts
Home & Garden
advertisement
Most Popular White Papers
advertisement

Content provided in partnership with
Thomson / Gale

Testing possible in dentist's office

USA Today (Society for the Advancement of Education),  Feb, 2006  

A novel test for lung cancer uses inner cheek cells to identify the disease in high-risk patients. Scientists have discovered that buccal mucosa, or cells scraped from the inner part of the cheek, may contain information that separates patients with lung cancer from high-risk negatives, a finding that may support cheek cell analysis as a simple and inexpensive early screening method for patients at risk for lung cancer.

"Previous research has shown that cell nuclear changes can extend a significant distance from the site of a malignancy. We have already conducted a successful clinical trial for our sputum test for lung cancer. New data suggest that the effects of lung cancer can also be measured as far away as skin cells in the mouth," explains lead researcher Bojana Turic, director of Clinical and Regulatory Affairs, Perceptronix, Inc., Vancouver, Canada. "Although a clinical test based on buccal cells is still in development, the method of analyzing cheek cells to detect cancer is showing interesting results."

Turic and colleagues analyzed randomized cheek scrapings of 150 confirmed lung cancer patients and 990 high-risk patients using Automated Quantitative Cytometry (AQC). Able to detect even subtle changes in buccal cell nuclei, the AQC system analyzes several thousand cells per specimen and reduces the data to a single score that predicts the likelihood of the presence of cancer. Of the buccal specimens collected, the AQC showed 66% sensitivity at 70% specificity overall, and 61% sensitivity for stage I lung cancer, which comprised 47 of the 150 cases.

"Stage I lung cancer is considered treatable, but most lung cancers are currently detected beyond Stage I," Turic notes. "We believe that early detection is the key to reducing lung cancer mortality and have focused our approach around the detecting stage"

Although the test is not intended for screening the general population, researchers are hopeful that the AQC method will become an accurate, noninvasive, inexpensive, and easy-to-administer lung cancer detection test for at-risk patients. "A sufficient amount of cells can be collected by scraping the inside of the cheek with a small wooden spatula similar to a tongue depressor," affirms Turic. "Ultimately, this test could be administered in primary care settings or dental offices. The procedure is simple enough that specimen collection could be done by patients themselves."

COPYRIGHT 2006 Society for the Advancement of Education
COPYRIGHT 2008 Gale, Cengage Learning